205 related articles for article (PubMed ID: 12494277)
1. A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa.
El-Thaher TS; Khatib S; Saleem M; Shnoudeh A; Badwan AA
Int J Impot Res; 2002 Dec; 14(6):453-61. PubMed ID: 12494277
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
Firoozi F; Longhurst PA; White MD
BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
[TBL] [Abstract][Full Text] [Related]
4. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro.
Taher A; Birowo P; Kamil ST; Shahab N
Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.
Noto T; Inoue H; Ikeo T; Kikkawa K
J Pharmacol Exp Ther; 2000 Sep; 294(3):870-5. PubMed ID: 10945835
[TBL] [Abstract][Full Text] [Related]
6. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
[TBL] [Abstract][Full Text] [Related]
7. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
8. Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathway.
McAuley IW; Kim NN; Min K; Goldstein I; Traish AM
J Androl; 2001; 22(4):623-8. PubMed ID: 11451359
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
Boolell M; Allen MJ; Ballard SA; Gepi-Attee S; Muirhead GJ; Naylor AM; Osterloh IH; Gingell C
Int J Impot Res; 1996 Jun; 8(2):47-52. PubMed ID: 8858389
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro.
Chuang AT; Strauss JD; Murphy RA; Steers WD
J Urol; 1998 Jul; 160(1):257-61. PubMed ID: 9628660
[TBL] [Abstract][Full Text] [Related]
11. KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.
Lin RJ; Wu BN; Lo YC; Shen KP; Lin YT; Huang CH; Chen IJ
Br J Pharmacol; 2002 Mar; 135(5):1159-66. PubMed ID: 11877322
[TBL] [Abstract][Full Text] [Related]
12. NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide.
Kalsi JS; Kell PD; Cellek S; Ralph DJ
Int J Impot Res; 2004 Apr; 16(2):195-200. PubMed ID: 14961060
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.
Toque HA; Teixeira CE; Lorenzetti R; Okuyama CE; Antunes E; De Nucci G
Eur J Pharmacol; 2008 Sep; 591(1-3):189-95. PubMed ID: 18593576
[TBL] [Abstract][Full Text] [Related]
14. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
[TBL] [Abstract][Full Text] [Related]
16. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
17. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro.
Jeremy JY; Ballard SA; Naylor AM; Miller MA; Angelini GD
Br J Urol; 1997 Jun; 79(6):958-63. PubMed ID: 9202566
[TBL] [Abstract][Full Text] [Related]
18. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
19. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides.
Traish A; Moreland RB; Huang YH; Kim NN; Berman J; Goldstein I
Mol Cell Biol Res Commun; 1999 Aug; 2(2):131-7. PubMed ID: 10542137
[TBL] [Abstract][Full Text] [Related]
20. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.
Filippi S; Crescioli C; Vannelli GB; Fazzini A; Natali A; Riffaud JP; Maggi M; Ledda F
Int J Androl; 2003 Apr; 26(2):101-8. PubMed ID: 12641828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
